SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending after a strong earnings report and news of a massive AI lease deal, positioning the company as a key player in AI infrastructure. The community is excited about the potential for a short squeeze and analysts raising price targets, while also debating entry points and long-term prospects. Bullish sentiment is fueled by the company's growth in the AI data center space, with some comparing it to other high-flying stocks in the sector.

SEALSQ Corp. is a holding company, which engages in the security of microcontrollers. It operates through the following geographical segments: North America, Europe, Middle East, Africa, Asia Pacific, and Latin America. It focuses on authentication process, digital certification, and covering individual patents of semiconductors. The company was founded on April 1, 2022 and is headquartered in Cointrin, Switzerland.

SEALSQ Corp

SEALSQ ($LAES) is surging due to a strategic partnership focused on developing quantum-resistant chips for U.S. defense applications, fueling speculation about lucrative government contracts. The community is buzzing about the company's growth potential and comparing it to other players in the quantum computing space, with some investors believing LAES is undervalued and predicting a significant climb.

RAGE GUY (RAGE) is a cryptocurrency inspired by the Rage Guy meme, one of the earliest and most recognizable characters from internet rage comics. The project captures the cultural legacy of early meme history and brings it onto the blockchain in tokenized form. It is designed as a community-driven digital asset that celebrates internet culture, nostalgia, and the role memes play in shaping online communities.

Rage Guy

RAGE CRYPTO is gaining traction as community members express excitement, referencing an imminent listing on Moonshot and calling for others to "RAGE" harder. Fueling the hype, some are alluding to potential breakouts and increased liquidity, while others point to the project's roots in OG internet meme culture. The community's focus remains on strong community building and promoting the idea of everyone making it.

GSR III Acquisition Corp engages in the merger, share exchange, asset acquisition, share purchase or reorganization with one or more businesses. The company was founded on May 10, 2023 and is headquartered in Austin, Texas.

GSR III Acquisition Corp. - Ordinary Shares- Class A

GSR III Acquisition Corp. Ordinary Shares

GSRT is trending due to the imminent ticker change to NKLR following its merger with Terra Innovatum, a micro-modular nuclear reactor developer; the change is expected to occur soon. Community members are excited about the potential, drawing comparisons to OKLO and highlighting the growing demand for nuclear energy. Discussions also include the stock's valuation relative to its peers and expectations for increased volume and volatility post-ticker change.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

Cleanspark is trending as the community discusses its potential for significant growth, drawing comparisons to IREN's valuation and anticipating news related to AI/HPC ventures. Bullish sentiment is fueled by the company's strong Bitcoin holdings, infrastructure ownership, and a recent mining update, with many expecting a run to higher price targets. Additionally, some are speculating on government involvement and the potential for a short squeeze.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending as chatter increases around a potential short squeeze, with the community noting high short interest and open call option volume. Recent developments, including a major financial endorsement and increased stake from Alphabet Inc., have boosted optimism. Discussions also involve TeraWulf's shift towards AI and high-performance computing, similar to peers in the sector.

One and one Green Technologies. Inc - Ordinary Shares - Class A

YDDL is trending due to its recent IPO and subsequent volatile price action, with the stock experiencing significant gains and drops. The community is actively discussing its low float, high insider ownership, and potential for both further gains and significant losses, with some expressing concerns about it being a pump and dump. Some traders are also looking at other AI and Green Tech names like $APLD and $HIVE.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust ($SLV) is trending as silver prices approach multi-decade highs, sparking discussions about a potential breakout. Community members are actively discussing the possibility of a short squeeze and the impact of supply deficits on prices. Some analysts point to a long-term cup and handle formation, suggesting a bullish outlook, while others debate potential pullbacks and profit-taking opportunities.

Zoracles

Zoracles ($ZORA) is trending due to a recent listing on Robinhood, driving increased volume and attention from new investors. The community is excited about the potential exposure to Robinhood's user base and the possibility of further listings on major exchanges. Some community members are drawing comparisons to social media platforms and anticipating a broader altcoin season.

Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending. The Office segment consists of the rental of office space and other tenant services, including tenant reimbursements, parking, and storage space rental. The Hotel segment involves the operation of hotel properties. The Lending segment focuses on loans to small businesses. The company was founded in 1993 and is headquartered in Dallas, TX.

Creative Media & Community Trust

CMCT is trending as traders discuss its potential for a short squeeze and parabolic moves, given its low float. Community members are debating its volatile history, reverse splits, and the possibility of a pump and dump, while also noting its current uptrend. Some traders are speculating about a potential break above key price levels that could trigger further gains.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Emerson Radio, one of the oldest consumer electronics manufacturers in the U.S., rose 20% in after-market trading on Wednesday after a sharp rally in recent sessions, piquing the interest of retail investors.The&nbsp;<a href="https://stocktwits.com/symbol/MSN">MSN stock</a> rose 65% in the previous two sessions to&nbsp;close at&nbsp;its highest level in over three years, without an apparent catalyst. The company is listed on the NYSE American, a platform for trading shares of small- and micro-cap companies operated by NYSE, and had a market cap of $15.7 million as of Wednesday.<figure class="image"><img style="aspect-ratio:614/71;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_09_at_11_44_09_AM_png_14d0034d6d.webp" alt="Screenshot 2025-10-09 at 11.44.09 AM.png" width="614" height="71"><figcaption>MSN sentiment and message volume as of October 9 | Source: Stocktwits</figcaption></figure>On Stocktwits, retail sentiment for the stock shifted to nearly the highest possible level, 'extremely bullish' (98/100) as of early Thursday, up from 'neutral' two days prior.&nbsp;Over the past 24 hours, the message volume for the ticker increased by 278%, while the number of watchers on Stocktwits jumped by 18%.Several users reported buying shares, adding the stock to their watchlists, and forecasting a price level of $2 or more in the coming days."$MSN Anything below $1 is a buy here," said one user.<stembedurl>https://stocktwits.com/InterstellerRides/message/631603439</stembedurl>New Jersey-based Emerson Radio produces and sells a range of home appliances, including microwave ovens, refrigerators, fans, clock radios, Bluetooth speakers, and televisions.Year-to-date, the company's shares have gained 77.4%.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Traders work on the floor of the New York Stock Exchange during morning trading on October 04, 2023 in New York City. 

Micro-Cap Emerson Radio Stock Surges By Two-Thirds In 2 Days, And Then Some More, Piquing Retail Traders

The home appliance company's shares snagged nearly the highest possible sentiment reading on Stocktwits.

Equity

The home appliance company's shares snagged nearly the highest possible sentiment reading on Stocktwits.


Special purpose acquisition company (SPAC) Churchill Capital Corp X (CCCX)&nbsp;shares were up over 4% in early premarket trading on Wednesday, poised to extend their winning streak to six sessions. The optimism over the shell company’s impending merger with the privately held quantum computing company Infleqtion has increased retail traders’ interest in Churchill Capital stock.The stock jumped 14% on Tuesday after Andrew Left’s Citron Research said the company is undervalued. Comparing Infleqtion with Rigetti (RGTI), the firm stated that the former actually sells quantum hardware, sensors, and atomic clocks, whereas the latter remains an underfunded science project.If both companies shared the same market capitalization, Churchill Capital should be trading at over $60, Citron said. Notwithstanding the stock's 80% rally seen since Sept. 8, when it announced its plan to merge with Infleqtion, it still traded at $18.23.Citron said, “Most investors don’t realize Infleqtion already has real defense and aerospace contracts — with DARPA and the Air Force Research Lab — and is shipping deployable quantum systems today. Rigetti isn’t close to that.” The firm recommended that investors should own three Churchill Corp shares for every single Rigetti stock they own.In the press statement announcing the SPAC deal, Churchill Capital stated in early September that Infleqtion has real-world deployments in computing and precision sensing and is poised to accelerate its scale. It touted that Infleqtion’s clientele included&nbsp; Nvidia, the U.S. Department of Defense and NASA, among others.To date, Infleqtion has sold three quantum computers and hundreds of quantum sensors, generating approximately $29 million in trailing twelve-month revenue as of June 30, 2025. The company expects roughly $50 million of booked and awarded business at year-end 2025, and has identified a potential customer pipeline exceeding $300 million.On Stocktwits, retail sentiment toward Churchill Capital stock improved further into the ‘extremely bullish’ territory by early Wednesday, and the message volume on the stream also remained ‘extremely high.’<figure class="image"><img style="aspect-ratio:626/55;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_08_at_4_24_48_AM_png_7c7969a459.webp" alt="Screenshot 2025-10-08 at 4.24.48 AM.png" width="626" height="55"><figcaption>CCCX sentiment and message volume as of 4:20 a.m. ET, Oct. 8 | source: Stocktwits</figcaption></figure>A bullish user expected the stock to open at $ 20 or higher amid the ongoing momentum.<stembedurl>https://stocktwits.com/moonstocks777/message/631429325</stembedurl>Another user, who identified themselves as one on the bullish camp, wondered whether it was too late to get into the stock and also whether it is a good long-term hold.<stembedurl>https://stocktwits.com/shercat06/message/631422369</stembedurl>Quantum computing stocks have been on a tear this year, having picked up from where they left off in late 2024, as investors are sold on the promise held by these companies.&nbsp; The&nbsp;<a href="https://stocktwits.com/symbol/QTUM">Defiance Quantum ETF (QTUM)</a> has gained nearly 38% year-to-date, outperforming the broader market and the tech sector.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-confluent-stock-is-soaring-over-19-in-today-s-premarket/ch6EfX6R3LN">Why Confluent Stock Is Soaring Over 19% In Today’s Premarket</a>

Quantum Computing, Quantum Physics, Quantum mechanics, Science, Technology. (Representative image courtesy of Just_Super via Getty Images)

Why SPAC Churchill Capital’s Stock Is Jumping Premarket Today

Citron recommended that investors should own three Churchill Corp shares for every single Rigetti stock they own.

American Battery Technology Co. (ABAT) stock was in the spotlight on Monday afternoon after it hit a 22-month high on bullish signals around the domestic lithium supply chain.&nbsp;The stock saw an 80% increase in user message count over the last 24 hours as of Monday morning on Stocktwits. At the time of writing,&nbsp;<a href="https://stocktwits.com/symbol/ABAT">American Battery stock</a> pared some of the gains and traded over 12% higher. Retail sentiment around the stock shifted to ‘bullish’ from ‘extremely bullish’ territory the previous day. Message volume changed to ‘high’ from ‘extremely high’ levels in 24 hours.<figure class="image"><img style="aspect-ratio:933/99;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_06_122707_png_70cf532499.webp" alt="ABAT’s Sentiment Meter and Message Volume as of 12:15 p.m. ET on Oct. 6, 2025 | Source: Stocktwits" width="933" height="99"><figcaption>ABAT’s Sentiment Meter and Message Volume as of 12:15 p.m. ET on Oct. 6, 2025 | Source: Stocktwits</figcaption></figure>A bullish Stocktwits user explained that the development of domestic lithium supply will also help with recycling.&nbsp;<stembedurl>https://stocktwits.com/venice868/message/631155879</stembedurl>Another user sounded optimistic about the company’s growth prospects over the next five years.&nbsp;<stembedurl>https://stocktwits.com/Nomortgage/message/631158239</stembedurl>Supporting these claims is the company’s partnership with Call2Recycle, announced on September 30, aiming to boost lithium-ion battery recycling nationwide.Under the new collaboration, batteries collected from Call2Recycle’s expansive drop-off network will be routed to American Battery’s facilities for processing. There, the company will utilize its proprietary closed-loop technology to extract valuable materials, such as lithium, nickel, cobalt, and manganese, with minimal environmental impact.In the fourth quarter, American Battery’s revenue rose 183% year-over-year (YoY) to $2.8 million, beating the analysts’ consensus estimate of $1.2 million, according to Fiscal AI data.&nbsp;In August, the company's Tonopah Flats Lithium Project received approval&nbsp;from the FAST-41 Permitting Council and the National Energy Dominance Council, accelerating its permitting and commercialization process.American Battery stock has gained over 122% year-to-date and over 416% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/plug-power-stock-hits-17-month-highs-on-optimism-around-company-hydrogen-projects/ch6R7LJR3gm">Plug Power Stock Hits 17-Month Highs On Optimism Around Company’s Hydrogen Projects</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Lithium Battery Recycling Solutions and Aktrion Group display reclaimed materials.

American Battery Stock Hits 22-Month Highs Driven By Bullish Momentum Surrounding Domestic Lithium Supply Chain

The stock experienced an 80% increase in user message count over the last 24 hours, as of Monday morning, on Stocktwits.

Shares of Skye Bioscience, Inc. (SKYE) dived 60% in the pre-market session on Monday after the company said that its Nimacimab alone did not cause weight loss as compared to placebo in a mid-stage trial.Preliminary analysis suggested that 200 mg of Nimacimab as a subcutaneous weekly dose was suboptimal as a monotherapy, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.skyebioscience.com/news-releases/detail/244/skye-bioscience-reports-topline-cbeyond-phase-2a-data-from-nimacimab-monotherapy-and-combination-clinical-trial">said</a>. The data, however, support the evaluation of higher dosing, the company said.Further, Nimacimab in combination with Novo Nordisk’s Semaglutide demonstrated a clinically meaningful magnitude of weight loss compared to Semaglutide alone, the company said. The positive observation supports further studies where Nimacimab is used with other therapies, it added.The drug alone and in combination demonstrated a clean safety profile, with no added gastrointestinal adverse events and no increases in neuropsychiatric adverse events reported resulting from treatment with Nimacimab, Skye said. Overall, the study, which enrolled 136 adults with overweight or obesity, had a discontinuation rate of 27%. Notably, 3.7% of the discontinuations were due to adverse events, with the placebo group contributing 60% of these discontinuations, according to the company.“With our preclinical data, toxicology safety margins, and PK modeling, we believe we have a path to support higher dosing, and we are evaluating the next stage of development to optimize dosing in potential future clinical trials," said Puneet Arora, Chief Medical Officer of Skye Bioscience. The company is now evaluating the data to determine the next steps for the development of the drug.SKYE stock is up 68% this year and by about 24% over the past 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

Why Did Skye Bioscience Stock Plummet A Whopping 60% Today?

The company stated that its investigational drug alone did not cause weight loss compared to the placebo in a mid-stage trial. 

Shares of Alto Neuroscience (ANRO) soared 54% on Friday afternoon after the company announced that the U.S. Food and Drug Administration granted Fast Track designation to ALTO-101 for the treatment of cognitive impairment associated with schizophrenia.Cognitive impairment is a core and disabling feature of Schizophrenia, a serious, disabling mental illness affecting thought, perception, and behavior. According to Alto, there are currently no approved treatments for cognitive impairment associated with schizophrenia.FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need. A company, whose drug has a Fast Track designation, may be eligible for more frequent meetings with the FDA to discuss the drug’s development plan, as well as for accelerated approval and priority review, subject to the fulfillment of relevant criteria.ALTO-101 is an inhibitor of the PDE4 enzyme that plays a key role in the brain by breaking down a molecule fundamental to learning and memory. By inhibiting the enzyme, the drug seeks to increase the levels of the molecule believed to improve cognitive function.Alto CEO Amit Etkin <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.altoneuroscience.com/news/news-details/2025/Alto-Neuroscience-Receives-FDA-Fast-Track-Designation-for-ALTO-101-for-the-Treatment-of-Cognitive-Impairment-Associated-with-Schizophrenia/default.aspx">termed</a> the designation a significant milestone. “Our Phase 1 data, which demonstrated significant and clinically relevant effects of ALTO-101 on both EEG measures and cognitive performance in healthy subjects, provides strong validation for its mechanism,” he added.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/ANRO">ANRO stock</a> rose from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:579/59;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_12_01_14_PM_png_f2a3fffa4a.webp" alt="ANRO's Sentiment Meter and Message Volume as of 12 p.m. ET on Oct. 03, 2025 | Source: Stocktwits" width="579" height="59"><figcaption>ANRO's Sentiment Meter and Message Volume as of 12 p.m. ET on Oct. 03, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user highlighted the company’s strong pipeline. Alto is seeking to develop treatments for mental health conditions, including bipolar depression, major depressive disorder, treatment-resistant depression (TRD), and schizophrenia.<stembedurl>https://stocktwits.com/Ccperk/message/630959482</stembedurl>Another user believes the FDA's Fast Track designation is the icing on the cake.<stembedurl>https://stocktwits.com/Ccperk/message/630949029</stembedurl>ANRO stock is up by 61% this year but down by 33% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rivian-reportedly-eyes-door-redesign-to-alleviate-safety-concerns-report/chCuVXzR3QQ">Rivian Reportedly Eyes Door Redesign To Alleviate Safety Concerns: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Alto Neuroscience logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Alto Neuroscience Stock Soars After FDA Grants Fast Track Designation To Schizophrenia Drug

FDA’s Fast Track designation is designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need.

Shares of nano-cap Nuburu, Inc. (BURU), a company specializing in blue laser technology for the welding and 3D printing industries, have been on a tear since the start of the week, amid trader optimism following a couple of announcements by the company.On Monday, the company disclosed a comprehensive update on its business performance, strategic initiatives, and outlook. As part of the update, the Colorado-based company said it expects to finalize binding agreements to pursue a controlling interest in Orbit S.r.l. by October 31, 2025, following its February announcement regarding the establishment of a Defense and Security hub.&nbsp;The company has established Nuburu Defense LLC to serve as its defense and security hub. It also explored the possibility of setting up a new operating office in Virginia. It touted a $19.4 billion total addressable market for the electronic warfare sector by 2028 and guided bookings of $500,000, primarily via Nuburu Defense, for the fourth quarter.&nbsp;Also this week, the company announced the implementation of a dual-CEO structure, effective October 1. “This strategic initiative complements Alessandro Zamboni's role as Executive Chairman and supports the company's ongoing transformation plan,” the company said. The transformation plan aims to achieve revenue growth starting in the fourth quarter through strategic acquisitions and international alliances, while also managing increased organizational complexity, it added.After closing at $0.1240 last Friday,&nbsp;<a href="https://stocktwits.com/symbol/BURU">Nuburu stock</a> has jumped 78% so far this week. On Thursday, the stock rallied by over 36% before closing at $0.307 and added 39% in after-hours trading. The seven-day message volume change on the Nburu stock stream was nearly 1,500%.On Stocktwits, retail sentiment toward the stock stayed ‘extremely bullish’ (98/100) by late Thursday, and the message volume also remained at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:620/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_10_03_at_2_09_06_AM_png_7b77ca3684.webp" alt="Screenshot 2025-10-03 at 2.09.06 AM.png" width="620" height="53"><figcaption>BURU sentiment and message volume as of 2 a.m. ET, Oct.3 | source: Stocktwits</figcaption></figure>Most retail watchers added the stock to their watchlist, aiming to capitalize on the recent momentum. A user regretted not buying ahead of the recent run. “Load the boat,” they said.<stembedurl>https://stocktwits.com/Noelle78/message/630889068</stembedurl>Another user pasted a screenshot of the overnight quote and said, “shorts in shambles.” The short interest in the stock is 9.20%, according to Koyfin data, although it has come off its June 2024 peak of 45%.<stembedurl>https://stocktwits.com/AriesFamous77/message/630888831</stembedurl>Nuburu stock has slumped 67% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/howard-lutnick-pushes-back-on-nvidia-uae-ai-chip-deal-report-says/chCu4zUR3fi">Howard Lutnick Pushes Back On Nvidia’s Multi-Billion-Dollar UAE AI Chip Deal? Report Says Delay Leaves Jensen Huang Frustrated</a>

Rising chart and reflection of business buildings: stock photo courtesy of Yuichiro Chino via Getty Images

Nuburu Retail Traders Say ‘Load the Boat’ as Penny Stock Surges 78% in a Week

The company’s transformation plan aims to achieve revenue growth starting in the fourth quarter through strategic acquisitions and international alliances, while also managing increased organizational complexity.

American Battery Technology Co. (ABAT) stock was in the spotlight on Tuesday morning after the company entered into a partnership with Call2Recycle, aiming to boost lithium-ion battery recycling nationwide.&nbsp;The agreement enables the critical battery materials company to broaden its services beyond commercial clients to include direct consumer participation in recycling efforts.Under the new collaboration, batteries collected from Call2Recycle’s expansive drop-off network will be routed to American Battery’s facilities for processing. There, the company will utilize its proprietary closed-loop technology to extract valuable materials like lithium, nickel, cobalt, and manganese with minimal environmental impact.“This partnership with Call2Recycle is a pivotal moment for ABTC, as it allows us to directly engage with consumers and extend the reach of our innovative recycling technologies,” said American Battery CEO Ryan Melsert.<a href="https://stocktwits.com/symbol/ABAT">American Battery stock</a> traded over 2% lower in Tuesday’s premarket. On Stocktwits, retail sentiment around the stock remained in ‘extremely bullish’ territory amid ‘extremely high’ message volume levels.<figure class="image"><img style="aspect-ratio:930/109;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_30_100432_png_7d195baaf1.webp" alt="ABAT’s Sentiment Meter and Message Volume as of 09:45 a.m. ET on Sep. 30, 2025 | Source: Stocktwits" width="930" height="109"><figcaption>ABAT’s Sentiment Meter and Message Volume as of 09:45 a.m. ET on Sep. 30, 2025 | Source: Stocktwits</figcaption></figure>The partnership also supports broader U.S. goals of reducing dependence on foreign sources for key minerals.“By creating a seamless and accessible pathway for the public to recycle their batteries, we are not only expanding our operational scope but also reinforcing the domestic supply chain for critical minerals, which is essential for a sustainable energy future,” said Melsert.Call2Recycle has already helped recycle more than 160 million pounds of used batteries.American Battery stock has gained over 101% year-to-date and over 364% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/coreweave-inks-14-point-2-billion-deal-with-meta-report/chDD7VeR3Bs">CoreWeave Inks $14.2 Billion Deal With Meta: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A worker is working on a lithium battery production line at Daoxian High-tech Industrial Development Zone in Yongzhou, China.

American Battery Technology Partners With Call2Recycle To Expand US Battery Recycling

The agreement enables the critical battery materials company to broaden its services beyond commercial clients to include direct consumer participation in recycling efforts.

American Battery (ABAT) stock rose about 1% in the early premarket session on Tuesday, following a nearly 18% rally on Monday. The stock was among the top five trending equity tickers on Stocktwits as of early Tuesday.American Battery shares&nbsp;have&nbsp;been on a broadly upward trajectory since the battery materials company reported its&nbsp;fiscal fourth-quarter 2025 results earlier this month.&nbsp;They have nearly doubled between September 18 and September 24,&nbsp;following the strong quarterly report.&nbsp;In Q4, revenue rose 183% year-over-year (YoY) to $2.8 million, as the company accelerated commercial operations to increase onshoring of critical mineral manufacturing.The Reno, Nevada-based company also said it was on a clear trajectory towards profitability as it continues to ramp up its operations. After a nearly 8% drop&nbsp;last Thursday,&nbsp;likely&nbsp;due to profit-taking, the stock rally resumed on Friday. The stock closed Monday’s session above the $5 threshold for the first time since late 2023.The stock also received support from the Trump administration’s interest in building&nbsp;stakes in companies having exposure to critical minerals amid the&nbsp;ongoing U.S.-China standoff over the trade of such minerals.On Stocktwits, retail sentiment toward American Battery stock remained ‘extremely bullish’ (82/100) as of early Tuesday, and the message volume on the stream was also ‘extremely high.’<figure class="image"><img style="aspect-ratio:617/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_30_at_5_10_36_AM_png_52cd95d6e3.webp" alt="Screenshot 2025-09-30 at 5.10.36 AM.png" width="617" height="53"><figcaption>ABAT sentiment and message volume as of 5:10 a.m. ET, Sept. 30 | source: Stocktwits</figcaption></figure>A bullish watcher signaled that they expect the rally to continue.<stembedurl>https://stocktwits.com/farmerboy511/message/630434399</stembedurl>Another user, however, remained wary. While noting that the recent price action showed significant volatility, they said they would wait for a “lower H% before considering entry.”<stembedurl>https://stocktwits.com/WallStreetBuyDip/message/630433207</stembedurl>American Battery stock,&nbsp;trading in the red for much of the year so far, turned positive for the year-to-date period following the recent gains.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/dow-nasdaq-futures-trade-flat-amid-government-shutdown-threat/chDwzs9R3BG">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/why-wolfspeed-stock-is-surging-50-premarket-today/chDDTR2R3BJ">Why Wolfspeed Stock Is Surging Over 50% Premarket Today</a>

Rising stock market chart on a trading board background.

American Battery Stock Rises In Premarket Today: What’s Powering The Stock Rally?

 The stock nearly doubled in value between September 18 and September 24, following a strong earnings report.

Fractyl Health (GUTS) announced on Friday that patients who stopped taking the GLP-1 class drug Tirzepatide and were treated with its Revita lost an additional 2.5% of their total body weight at three months in a trial. At the time of writing, shares of the company traded 28% higher on Friday afternoon.The study was designed to evaluate the Revita procedure in adults with obesity who achieved at least 15% total body weight loss with Tirzepatide, the active ingredient in Eli Lilly’s blockbuster weight loss drug Zepbound. Those who received a sham procedure after discontinuing Zepbound regained 10% total body weight in the study at three months, the company said.Revita is Fractyl’s lead product candidate. The procedure is designed to reverse damage to intestinal nutrient-sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets by remodeling the inner wall of the first part of the small intestine.“These results are clinically and statistically significant and provide randomized, blinded evidence that drug-free, durable weight maintenance is possible,” the company said, while adding that the study also supports Revita in post-GLP-1 weight maintenance.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/26/3156942/0/en/Fractyl-Health-Announces-Groundbreaking-Data-from-REMAIN-1-Midpoint-Cohort-Showing-Revita-Maintained-Weight-Loss-After-GLP-1-Discontinuation.html">stated</a> that no serious adverse events related to Revita were identified in the study, and side effects were infrequent and mild. The firm expects to file with the U.S. Food and Drug Administration for the approval of Revita in the second half of 2026.On Friday, the company also <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/09/26/3156951/0/en/Fractyl-Health-Announces-Pricing-of-60-Million-Underwritten-Offering-of-Common-Stock.html">announced</a> the pricing of an underwritten offering of 60 million shares of its common stock at $1.00 per share, representing a discount of about 1% from the stock’s closing price on Thursday. The gross proceeds from the offering are expected to be about $60 million, the company added.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/GUTS">GUTS stock</a> rose from ‘bullish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘high’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:622/66;" src="https://news.stocktwits-cdn.com/Screenshot_2025_09_26_at_1_00_54_PM_png_90a4342a59.webp" alt="GUTS' Sentiment Meter and Message Volume as of 1:01 p.m. ET on Sept. 26, 2025 | Source: Stocktwits" width="622" height="66"><figcaption>GUTS' Sentiment Meter and Message Volume as of 1:01 p.m. ET on Sept. 26, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed disappointment at the offering.<stembedurl>https://stocktwits.com/Stmkr/message/630122910</stembedurl>GUTS stock is down 38% this year and by about 49% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/uber-reportedly-expects-non-restaurant-deliveries-to-surge-faster-than-previously-expected/chDVlUmR3eW">Uber Reportedly Expects Non-Restaurant Deliveries To Surge Faster Than Previously Expected</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

GUTS Stock Rallied About 28% Today – Here’s Why

Fractyl Health expects to file with the U.S. Food and Drug Administration for the approval of Revita in the second half of 2026.

Shares of PepGen (PEPG) more than doubled on Thursday morning after multiple analysts raised their price targets on the stock following the release of positive clinical data from an early-stage study in patients with myotonic dystrophy type 1.Wedbush raised its price target on PepGen to $9 from $7 and kept an ‘Outperform’ rating on the shares, while H.C. Wainwright hiked its price target on the stock to $12 from $8.Myotonic dystrophy type 1 (DM1) is a progressive disorder that primarily affects skeletal, cardiac, and smooth muscle. It is estimated to affect about 40,000 patients in the U.S.The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.pepgen.com/news-releases/news-release-details/pepgen-announces-highest-mean-splicing-correction-reported-dm1">announced</a> on Wednesday that a 53.7% mean splicing correction was observed in DM1 patients following a single 15 mg/kg dose of its PGN-EDODM1, which is higher than any previously reported splicing correction in DM1 patients. All patients who received the dose in the trial showed an improvement in splicing correction, the company noted.“Since mis-splicing is the underlying cause of DM1, we believe high levels of splicing correction have the potential to reverse the underlying molecular defects, and produce functional improvements in multiple outcome measures, including myotonia and muscle weakness, in repeat dose studies,” said Paul Streck, Executive Vice President of Research and Development at PepGen.The company previously reported mean splicing correction of 12.3% and 29.1%, respectively, with 5mg/kg and 10mg/kg doses of PGN-EDODM1.The investigational candidate was well-tolerated at a dose of 15 mg/kg, and no serious treatment-related adverse events were identified, the company stated. However, one patient had to receive oral antihistamines for treatment-related adverse events, it said.PepGen's nearly 54% correction sets a new benchmark and "strongly suggests that repeat dosing could yield clinically meaningful functional benefit," contends H.C. Wainwright.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/PEPG">PEPG stock </a>rose from 'neutral' to 'extremely bullish' territory over the past 24 hours, while message volume stayed at 'extremely high' levels.&nbsp;PEPG stock is up 51% this year but down approximately 34% over the past 12 months.&nbsp;Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/carmax-stock-tumbles-after-q2-earnings/chDlO6OR348">Why Did CarMax Stock Tumble 24% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

PepGen Stock More Than Doubles On Thursday – Check Out The New Price Targets On Wall Street

Wedbush raised its price target on PepGen to $9 from $7 and kept an ‘Outperform’ rating on the shares, while H.C. Wainwright hiked its price target on the stock to $12 from $8.

BlackRock Institutional Trust Company N.A. - iShares Micro-Cap ETF

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$154.34
Prev Close	$154.20
Open	$154.41
Dividend Yield	N/A
50-Day Moving Average	$142.56
Beta	N/A
Avg. Volume	40,872.67
PE Ratio	N/A

52-Week High	$155.00
52-Week Low	$95.25
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IWC
iShares Micro-Cap ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IWC News

IWCiShares Micro-Cap ETF